Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/1999
06/17/1999CA2311281A1 Cyp7 promoter-binding factors
06/17/1999CA2255286A1 Galanin transgenic mice
06/17/1999CA2255109A1 Mammalian brainiac genes
06/16/1999EP0922769A1 Iron-casein complex hydrolyzate and process for the production thereof
06/16/1999EP0922768A2 Oncogene or virus-driven expression systems
06/16/1999EP0922764A1 Soybean ADP ribosylation factor
06/16/1999EP0922763A1 Inwardly rectifying potassium channel gene and protein
06/16/1999EP0922762A1 Drug binding protein
06/16/1999EP0922761A1 Monoclonal antibody specific to anti-human fibrin monomer, process for producing the same, hybridomas, and immunoassay method
06/16/1999EP0922760A2 Transgenic animal not expressing endogenous osteoclastogenesis inhibitory factor (OCIF)
06/16/1999EP0922710A1 PEPTIDES PROMOTING THE ACTIVATION OF LATENT TGF-$g(b) AND METHOD FOR SCREENING TGF-$g(b) ACTIVITY REGULATORS
06/16/1999EP0922455A1 Hiv-1 protease inhibitors, process for producing the same, and medicinal compositions
06/16/1999EP0922228A2 Assaying d-amino acids in body fluids
06/16/1999EP0922225A1 Assay for quantifying arthritic conditions
06/16/1999EP0922111A1 Induction of t cell tolerance using a soluble molecule that can simultaneously block two costimulatory pathways
06/16/1999EP0922110A2 Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat
06/16/1999EP0922109A1 Novel yeast promoters suitable for expression cloning in yeast and heterologous expression of proteins in yeast
06/16/1999EP0922105A2 Infectious papillomavirus pseudoviral particles
06/16/1999EP0922103A1 NEW $i(BRUCELLA) ANTIGENS, RECOMBINANT POLYPEPTIDES, NUCLEIC ACIDS CODING FOR THE SAME AND USE THEREOF IN DIAGNOSTIC AND PROPHYLACTIC METHODS AND KITS
06/16/1999EP0922102A1 Hepatocyte growth factor receptor agonists and uses thereof
06/16/1999EP0922101A1 Egf-like factor from chromaffin granules and glia cell-derived neurotrophic factor with survival-promoting activity on daergic neurons
06/16/1999EP0922100A2 Secreted proteins and polynucleotides encoding them
06/16/1999EP0922099A1 Fas ligand-like protein, its production and use
06/16/1999EP0922098A1 Sexing gene
06/16/1999EP0922096A1 Transgenic plants resistant to geminivirus infection
06/16/1999EP0922059A1 Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions
06/16/1999EP0922058A2 Self-aligning peptides derived from elastin and other fibrous proteins
06/16/1999EP0922057A1 Myelin oligodendrocyte glycoprotein peptides and uses thereof
06/16/1999EP0922056A1 New fibrinogen binding protein originating from coagulase-negative staphylococcus
06/16/1999EP0922055A1 Conotoxin peptide pviia
06/16/1999EP0922053A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS A TUMOR SUPPRESSOR
06/16/1999EP0922052A1 Rat ob receptors and nucleotides encoding them
06/16/1999EP0921820A1 Gene therapy for obesity
06/16/1999EP0921819A1 Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin
06/16/1999EP0921818A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
06/16/1999EP0921816A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
06/16/1999EP0921814A1 Method for increasing viability and transformation efficiency of bacteria during storage at low temperatures
06/16/1999EP0921813A1 Immunogenic preparation and method for improving the productivity of ruminant animals
06/16/1999EP0921810A2 Method of reducing the severity of host vs. graft reaction by down-regulating hsp60 autoimmunity
06/16/1999EP0921805A1 Peptides recognized by melanoma-specific a1-, a2- and a3-restricted cytotoxic lymphocytes, and uses therefor
06/16/1999EP0921719A1 Genes enhancing disease resistance in plants
06/16/1999EP0797582A4 Phosphotyrosine assay and peptides for use therein
06/16/1999EP0670900B1 Bacillus thuringiensis isolates active against lepidopteran pests
06/16/1999EP0669976B1 Screening method using transcription factor DP-1
06/16/1999EP0542934B1 Use of somatostatin analogues for treating melanomas
06/16/1999EP0491828B1 PEPTIDES FROM GTPase-ACTIVATING PROTEIN (GAP), DIAGNOSTIC AND THERAPEUTIC USE THEREOF
06/16/1999CN1219969A Transferrin binding proteins of pasteurella haemolytica and vacc ines containing same
06/16/1999CN1219968A Antibodies to ED-8 domain of fibronectin, their construction and uses
06/16/1999CN1219967A Glial cell line-derived neurotrophic factor receptor
06/16/1999CN1219966A Plant sugar sensing protein and uses thereof
06/16/1999CN1219939A Method and apparatus for preparing acellular red blood cell substitute
06/16/1999CN1219938A Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (VIP)
06/16/1999CN1219881A Caprine arthritis-encephalitis virus provides immunoprotection against HIV-1 infection
06/16/1999CN1043647C Peptide compound
06/15/1999US5912415 Arabidopsis spindly gene, methods of identification and use
06/15/1999US5912411 Mice transgenic for a tetracycline-inducible transcriptional activator
06/15/1999US5912337 Parasitic helminth p22U proteins
06/15/1999US5912336 Dna molecule coding for an iron-controlled protein found in gram-negative bacteria outer membranes; treatment of gonorrhea and meninigitis
06/15/1999US5912335 A polynucleotide sequence that codes human 7-transmembrane receptor protein; treatment of infections, hiv, eating disorders, cancers, heart diseases, mental illnesses, huntington's disease, tourett's and parkinson's disease
06/15/1999US5912334 DNA encoding equine interleukin-1
06/15/1999US5912329 Method for purification of a mixture of hydroxamate derivatized protein and native protein
06/15/1999US5912327 Treating with low concentrations of chaotropic agents to solubilize protein, diluting solution with 10 to 20 volumes of buffer ph 4.5 to refold protein, recovering protein
06/15/1999US5912326 A recombinant polypeptide that is a receptor ligand for the oncogene, erbb; treatment of central nervous diseases, cardiac arrythmias, and amyotrophic lateral sclerosis
06/15/1999US5912325 A polypeptide which codes for an epitope of an animal growth hormone; animal growth enhancer
06/15/1999US5912324 Interferon-gamma (IFN-γ) inducing factor (IGIF, IL-18) purified from murine liver
06/15/1999US5912323 A purified vibrio cholera tight junction toxin receptor; antiinflammatory agents for treatment of gastrointestinal conditions
06/15/1999US5912322 Polypeptide with either deletions or substitions of cysteine residues; when fused with transforming growth factor-alpha protein has decreased killing activity and increased receptor-binding activity; anticarcinogenic agents
06/15/1999US5912236 Broad-spectrum tumor suppressor genes gene products and methods for tumor suppressor gene therapy
06/15/1999US5912234 Integrin-binding peptides
06/15/1999US5912232 Administering peptides having antagonist activity for alpha chemokines, for treatment of autoimmune and inflammatory disorders
06/15/1999US5912231 Substitution analogues of magainin peptides
06/15/1999US5912230 Polypeptides with specified sequences
06/15/1999US5912229 Use of a pharmaceutical composition comprising an appetite-suppressing peptide
06/15/1999US5912227 Method of enhancing nutrient uptake
06/15/1999US5912224 Methods and compositions for enhancing cellular response to TGF-β ligands
06/15/1999US5912183 Amino acid sequences with phosphorylated tyrosine which interact with intracellular signal transducers and interfere with signal transduction; antimetastasis/anticarcinogenic/ antitumor/antiproliferative agents
06/15/1999US5912177 Stem cell immobilization
06/15/1999US5912176 Antibodies against a host cell antigen complex for pre and post exposure protection from infection by HIV
06/15/1999US5912173 Vector containing mutated interleukin-2r gamma nucleic acid when transfected into rodents, homologous recombination with x-chromosomes resulting in defective cells; animal models for severe combined immunodeficiency diseases
06/15/1999US5912172 Endowing lymphocytes with antibody specificity
06/15/1999US5912171 Amino acid transporters and uses
06/15/1999US5912170 Redirection of cellular immunity by protein-tyrosine kinase chimeras
06/15/1999US5912168 CD95 regulatory gene sequences
06/15/1999US5912167 Autocatalytic cleavage site and use thereof in a protein expression vector
06/15/1999US5912166 Compounds and methods for diagnosis of leishmaniasis
06/15/1999US5912160 A protein invovled in tyrosine kinase activation pathway; antitumor and antidiabetic agents
06/15/1999US5912144 A polypeptide having an amino acid sequence for an immediate early response gene/g protein couplec receptor; anticarcinogenic, antiproliferative and antitumor agents
06/15/1999US5912143 Polynucleotides encoding a human mage protein homolog
06/15/1999US5912142 Gene product over expressed in cancer cells
06/15/1999US5912141 Nucleic acids encoding tumor virus susceptibility genes
06/15/1999US5912137 Assays for protein kinases using fluorescent
06/15/1999US5912136 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
06/15/1999US5912133 Isolating primitive hematopoietic cells by binding cells withantibodies specific for fetal liver kinase, a surface receptor protein tyrosine kinase, and separating
06/15/1999US5912132 Test kit contains culture of frozen cells transfected with dna coding for receptors and marker gene, a growth medium, and a reagent for marker detection; for screening ligand libraries
06/15/1999US5912131 Peptides produced by digestion of bone collagen with protease and purified to contain a 3-hydroxypyridinium crosslink; also bind to monoclonal antibody 1h11
06/15/1999US5912130 Human Homolog of the rat G protein gamma-5 subunit
06/15/1999US5912128 Human ena/VASP-like protein splice variant
06/15/1999US5912123 Detection of the leptin receptor in reproductive organs and methods for regulating reproductive biology
06/15/1999US5912122 A polynucleotide coding for a central nervous system g protein receptor; therapy for neurodegenerative disorders
06/15/1999US5912121 Obtaining dna samples from patient coding for tropomyosin or cardiac troponin t proteins; determining if mutations are present; early, noninvasive, assymptomatic diagnosis